Insulet PODD Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's pre-tax income?
- Insulet (PODD) reported pre-tax income of $113M in Q1 2026.
- How has Insulet's pre-tax income changed year-over-year?
- Insulet's pre-tax income increased by 134.4% year-over-year, from $48.2M to $113M.
- What is the long-term trend for Insulet's pre-tax income?
- Over 4 years (2021 to 2025), Insulet's pre-tax income has grown at a 101.7% compound annual growth rate (CAGR), from $20.5M to $339.6M.
- What does pre-tax income mean?
- The company's profit before paying income taxes.
- How do you interpret pre-tax income?
- An increase indicates stronger operational performance or reduced non-operating costs, while a decrease suggests declining margins or higher interest burdens.
- How does pre-tax income compare across companies?
- Standard across all public companies; peers in the medical device sector typically show consistent growth in this metric as they scale.